Today we will run through one way of estimating the intrinsic value of Vor Biopharma Inc. (NASDAQ:VOR) by taking the expected future cash flows and discounting them to today's value. One way to ...

Less than two months after Vor Bio telegraphed a strategic review, the former cell therapy biotech has made a surprise comeback with a potential $4 billion deal licensing a China-made autoimmune ...

Shares of Vor Bio are up 120% in pre-market trade on Thursday. For More Such Health News, visit rttnews.com. The views and opinions expressed herein are the views and opinions of the author and do ...

Vor Bio is licensing global rights to a fusion protein that inhibits two targets to potentially treat the neuromuscular disorder generalized myasthenia gravis. It’s a pivot for Vor, which last ...

Vor Biopharma shares surge 43% after licensing deal, $175M raise, and CEO transition.

RFK Jr.’s Vaccine Panel Has a New Approach: Question Everything Immunizations ‘are not all good or bad,’ says the chair of the overhauled committee By Liz Essley Whyte Share ...

Bill Goldberg could never be accused of subtlety in his career. And the former WCW Champion is maintaining his 1,000 mile per hour approach to his final ever ma ...

Arsenal make formal contact with Chelsea over the potential signing of England winger Noni Madueke.

Now in its sixth month, President Trump's administration has become the antithesis of progress, many LGBTQ Americans say.

Good Job I Have an Approach to Business Meetings That Might Be Deeply Off-Putting. I Can’t Help It!

When President Donald Trump traveled here Tuesday for a consequential summit of NATO leaders, he arrived toting a freshly brokered ceasefire he hoped could prove to his skeptics — including at ...